DermTech, Inc. DMTK
0.09 0.00 (+0.00%)
At closeJun 26, 2024, 4:00 PM EDT
0.089 Day range 0.1002
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 1.50
Ratings (-1m) 4 2 buy · 2 hold · 0 sell
- Strong buy0
- Buy2
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 4
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.52 | -0.52 – -0.52 | -0.99 | +47.5% | 3.95M | +7.0% | 1 |
| Next quarter | -0.52 | -0.52 – -0.52 | -0.57 | +8.8% | 4.19M | 0.0% | 1 |
| Current year | -2.12 | -2.12 – -2.12 | -3.09 | +31.4% | 16.20M | +5.9% | 1 |
| Next year | -2.08 | -2.08 – -2.08 | -2.12 | +1.9% | 17.40M | +7.4% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 6, 2023 | BTIG | Maintained | Buy | Buy |
| Mar 28, 2023 | TD Cowen | Maintained | — | Outperform |
| Nov 8, 2022 | Stephens & Co. | Maintained | — | Overweight |
| Nov 7, 2022 | BTIG | Maintained | — | Buy |
| Nov 3, 2022 | William Blair | Downgrade | Outperform | Market Perform |
| Aug 16, 2022 | Oppenheimer | Maintained | — | Outperform |
| Aug 14, 2022 | BTIG | Maintained | — | Buy |
| Jan 6, 2022 | Stephens & Co. | Initiated | — | Overweight |
| May 2, 2021 | BTIG | Initiated | — | Buy |
| Jan 21, 2021 | Oppenheimer | Initiated | — | Outperform |
| Oct 29, 2020 | William Blair | Initiated | — | Outperform |
| Sep 9, 2020 | Cowen & Co. | Initiated | — | Outperform |